A forum for researchers, students and applicants in the field of cyclodextrin technology
In the last decade, nanotechnological progress has generated new opportunities to improve the safety and efficacy of conventional anticancer therapies.
In this study, understanding the in vivo fate of β-cyclodextrin, a LC-MS/MS method was developed to facilitate simultaneous quantitative analysis
The 4th Annual Injectable Drug Delivery Conference will be held on 11th and 12th May 2022 in London, UK. There
Direct extrusion of hydroxypropyl beta-cyclodextrin (HP-β-CD)-based powder blends using the most innovative 3D printing technology, Direct Powder Extrusion (DPE), is
Na2B12I12 has many of the properties desired by an X-ray contrast agent but is lethal at the concentrations needed for medical
An innovative application of sulfobutylether-β-CD (SBE-βCD) regarding the preparation of spherical and monodispersed silver nanoparticles (AgNPs) was recently described [1].
In recent years, the use of CD derivatives in combination with nanomaterials has shown to be a promising strategy for
D-maltose-clicked derivative of β-cyclodextrin (β-CD-M) was synthesized to compare and investigate its capability as an anticancer drug nanocarrier [1]. The
Background: Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are
The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as
